ASCEND
BY NTHRYS

NTHRYSInternshipsAi Drug Repurposing

AI Pandemic Drug Repurposing Response Research

Ai Drug Repurposing
AI Pandemic Drug Repurposing Response Research
Focused area
Variant
Pay · Join
Step 3 of 5Choose focused area
Field
Category
Focused area
You might prefer
AI Knowledge Graph Drug Repurposing ResearchMachine Learning Omics-Driven Repurposing StudiesAI Drug Repurposing for Rare Disease ResearchDeep Learning for Drug Side Effect RepurposingAI Literature Mining for Repurposing SignalsAI Polypharmacology-Based Repurposing ResearchAI Patient Data-Driven Drug Repurposing ResearchAI Network Medicine Drug Repurposing ResearchAI Combination Therapy Repurposing StudiesAI Molecular Docking Drug RepurposingGraph Neural Networks Drug Target PredictionTransformer Models Biomedical Text MiningAI Cancer Drug Repurposing PipelineFederated Learning Drug Discovery NetworksSMILES-Based Drug Representation LearningAI Antimicrobial Resistance Drug RepurposingClinical Trial Data Mining RepurposingAI Neurodegenerative Disease RepurposingReinforcement Learning Drug OptimizationProtein Structure AI Drug RepurposingAI Cardiovascular Drug Repurposing ResearchChemical Similarity Network Drug DiscoveryMulti-Task Learning Disease PredictionAI Inflammatory Disease Drug RepurposingSequence-Based Protein Target DiscoveryMetabolomics Data Integration Drug RepurposingAI Infectious Disease Drug RepurposingTransfer Learning Drug Response PredictionAI Autoimmune Disease Drug RepurposingGene Expression Drug Response ModelingAI Metabolic Disease Drug RepurposingAttention Mechanisms Drug Target RankingAI Pulmonary Disease Drug RepurposingPharmacophore Matching AI Drug DiscoveryAI Renal Disease Drug RepurposingSynthetic Data Generation Drug TrainingAI Gastrointestinal Disease Drug RepurposingCausal Inference Drug Effect AttributionAI Ophthalmologic Drug RepurposingTemporal Disease Progression Drug ModelingAI Dermatological Drug Repurposing ResearchCross-Species Drug Efficacy TranslationAI Orthopedic Disease Drug RepurposingExplainable AI Drug Repurposing ModelsAI Endocrine Disease Drug RepurposingZero-Shot Learning Drug RepurposingAI Psychiatric Drug Repurposing StudiesVariational Autoencoder Drug DiscoveryAI Biomarker Discovery Drug Repurposing

AI Pandemic Drug Repurposing Response Research

Internship studying rapid repurposing pipelines that shortlist deployable drugs when outbreaks strike. Includes mentored hands-on analysis sessions.

The focused areas below are internship topics in varied working formats. Pick one, then choose your internship type, mode… Read more

🎓 TYPE
🌐 MODE
📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal
🔍

Showing 110 of 10

Machine Learning Models for Rapid Viral Protein Structure Prediction
Research investigates deep learning architectures that predict three-dimensional structures of novel viral proteins within hours rather than months of experimental determination. This accelerates drug repurposing by enabling rapid identification of existing compounds that can bind to critical viral targets.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £759
R · £1,104
3 Months
A · £998
T · £1,220
R · £1,774
6 Months
A · £2,218
T · £2,711
R · £3,943
14 more durationsView Titles →
Graph Neural Networks for Drug-Protein Interaction Network Mapping
Research explores how graph-based AI systems model complex interactions between pharmaceutical compounds and viral/host proteins during pandemic outbreaks. The approach generates comprehensive interaction networks that reveal unexpected drug candidates with therapeutic potential against emerging pathogens.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £753
R · £1,095
3 Months
A · £990
T · £1,210
R · £1,760
6 Months
A · £2,200
T · £2,689
R · £3,911
14 more durationsView Titles →
Natural Language Processing for Mining Historical Clinical Trial Data
Research applies advanced NLP techniques to extract relevant safety, efficacy, and pharmacokinetic information from decades of archived clinical trial documents and medical literature. This systematically identifies drug candidates with favorable safety profiles that warrant rapid repurposing evaluation during pandemics.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £747
R · £1,086
3 Months
A · £982
T · £1,200
R · £1,746
6 Months
A · £2,182
T · £2,667
R · £3,879
14 more durationsView Titles →
Federated Learning Systems for Privacy-Preserving Global Drug Response Data
Research develops decentralized AI models that aggregate patient treatment outcomes across international healthcare systems without exposing sensitive health information. This enables real-time, globally-coordinated drug efficacy assessment and repurposing recommendations during simultaneous pandemic waves.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £784
R · £1,140
3 Months
A · £1,031
T · £1,260
R · £1,832
6 Months
A · £2,290
T · £2,799
R · £4,071
14 more durationsView Titles →
Physics-Informed Neural Networks for Viral Mutation Prediction and Adaptation
Research combines physical constraints of viral biology with deep learning to predict how pathogens mutate in response to existing antiviral drugs. This proactive approach identifies drug combinations that maintain efficacy against predicted viral variants months before they emerge.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £772
R · £1,122
3 Months
A · £1,015
T · £1,240
R · £1,803
6 Months
A · £2,254
T · £2,755
R · £4,007
14 more durationsView Titles →
Transfer Learning Frameworks Across Coronavirus and Filovirus Drug Targets
Research investigates how AI models trained on known drug-coronavirus interactions can be rapidly adapted to identify promising compounds against structurally-similar viral families during novel outbreaks. This cross-pathogen knowledge transfer dramatically reduces time required to generate repurposing hypotheses.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £784
R · £1,140
3 Months
A · £1,031
T · £1,260
R · £1,832
6 Months
A · £2,290
T · £2,799
R · £4,071
14 more durationsView Titles →
Variational Autoencoders for De Novo Drug Molecule Generation and Screening
Research employs generative AI to synthesize novel molecular structures with predicted antiviral activity while computationally screening billions of candidates against pandemic target proteins. This generates optimized compounds for emergency manufacturing while simultaneously identifying approved drugs suitable for rapid repurposing.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £827
R · £1,203
3 Months
A · £1,088
T · £1,329
R · £1,933
6 Months
A · £2,416
T · £2,953
R · £4,295
14 more durationsView Titles →
Reinforcement Learning for Optimal Drug Combination Sequencing in Outbreak Response
Research applies adaptive AI algorithms that learn which drug combinations, dosing sequences, and patient stratifications produce superior outcomes during real-time pandemic treatment trials. This generates evidence-based repurposing protocols that evolve daily as new clinical data emerges.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £821
R · £1,194
3 Months
A · £1,079
T · £1,319
R · £1,919
6 Months
A · £2,398
T · £2,931
R · £4,263
14 more durationsView Titles →
Attention Mechanisms for Identifying Secondary Binding Sites in Repurposed Antivirals
Research uses interpretable AI models with attention layers to discover previously-unknown secondary binding mechanisms of approved drugs against novel viral targets. These unexpected interactions often confer additional therapeutic benefits that accelerate clinical translation of repurposed candidates.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £719
R · £1,046
3 Months
A · £946
T · £1,156
R · £1,681
6 Months
A · £2,101
T · £2,567
R · £3,734
14 more durationsView Titles →
Ensemble Meta-Learning Systems for Few-Shot Drug Efficacy Prediction in Novel Pathogens
Research develops meta-learning frameworks that rapidly adapt to new viral pathogens using minimal initial efficacy data, drawing on knowledge from hundreds of previous drug-pathogen studies. This enables confident repurposing recommendations within days of pathogen identification, before comprehensive experimental validation is complete.
Academic (A)Tech (T)Research (R)
1 Month
A · £268
T · £775
R · £1,127
3 Months
A · £1,019
T · £1,245
R · £1,811
6 Months
A · £2,263
T · £2,766
R · £4,023
14 more durationsView Titles →